Current assets decreased 21.2%
Current assets changed -21.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$598.5M→$471.8M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ASAN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities increased 20.9%
Current liabilities changed +20.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$424.1M→$512.9M4 prior comparisons
Current ratio decreased 34.8%
Current ratio changed -34.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
1.41→0.924 prior comparisons
Working capital / assets moved 2479 bp lower
Working capital / assets changed -2479 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
19.75%→-5.04%4 prior comparisons
Operating margin moved 607 bp higher
Operating margin changed +607 basis points from the comparable as-filed period.
-25.11%→-19.05%2 prior comparisons
Gross margin moved 374 bp lower
Gross margin changed -374 basis points from the comparable as-filed period.
89.73%→85.99%2 prior comparisons
Working capital changed across a sign change
Working capital changed -123.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
$174.4M→-$41.1M4 prior comparisons
SBC / revenue moved 554 bp lower
SBC / revenue changed -554 basis points from the comparable as-filed period.
31.56%→26.03%2 prior comparisons
Operating income increased 16.7%
Operating income changed +16.7% from the comparable as-filed period.
-$49.5M→-$41.2M2 prior comparisons
Free-cash-flow proxy increased 15.6%
Free-cash-flow proxy changed +15.6% from the comparable as-filed period.
$38.5M→$44.6M3 prior comparisons
Operating cash flow increased 15.6%
Operating cash flow changed +15.6% from the comparable as-filed period.
$39.8M→$46.0M3 prior comparisons
Net income increased 19.0%
Net income changed +19.0% from the comparable as-filed period.
-$48.4M→-$39.2M2 prior comparisons
Total assets decreased 7.6%
Total assets changed -7.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$883.2M→$816.1M4 prior comparisons
Cash & equivalents increased 19.2%
Cash & equivalents changed +19.2% from the comparable as-filed period.
$184.1M→$219.6M2 prior comparisons
Revenue increased 9.9%
Revenue changed +9.9% from the comparable as-filed period.
$196.9M→$216.4M2 prior comparisons
Trade receivables increased 13.6%
Trade receivables changed +13.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$69.2M→$78.6M4 prior comparisons
R&D / revenue moved 254 bp lower
R&D / revenue changed -254 basis points from the comparable as-filed period.
40.31%→37.76%2 prior comparisons
Stock-based compensation decreased 9.4%
Stock-based compensation changed -9.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$62.2M→$56.3M2 prior comparisons
Capex / revenue moved 3 bp higher
Capex / revenue changed +3 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.66%→0.69%2 prior comparisons
Capital expenditure increased 15.2%
Capital expenditure changed +15.2% from the comparable as-filed period.
$1.3M→$1.5M3 prior comparisons
Operating cash-flow margin moved 105 bp higher
Operating cash-flow margin changed +105 basis points from the comparable as-filed period.
20.23%→21.28%2 prior comparisons
Free-cash-flow margin moved 102 bp higher
Free-cash-flow margin changed +102 basis points from the comparable as-filed period.
19.57%→20.59%2 prior comparisons
Gross profit increased 5.3%
Gross profit changed +5.3% from the comparable as-filed period.
$176.7M→$186.1M2 prior comparisons
Receivables / revenue moved 118 bp higher
Receivables / revenue changed +118 basis points from the comparable as-filed period.
35.15%→36.34%2 prior comparisons
Research & development increased 3.0%
Research & development changed +3.0% from the comparable as-filed period.
$79.4M→$81.7M2 prior comparisons
Free-cash-flow proxy increased 511.1%
Free-cash-flow proxy changed +511.1% from the comparable as-filed period. The change ranks at the 83th percentile of 6 prior comparable changes.
$6.1M→$37.4M6 prior comparisons
Capital expenditure increased 340.1%
Capital expenditure changed +340.1% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes. This reverses 5 consecutive comparable moves in the opposite direction.
$638,000→$2.8M6 prior comparisons
Operating cash flow increased 495.0%
Operating cash flow changed +495.0% from the comparable as-filed period. The change ranks at the 83th percentile of 6 prior comparable changes.
$6.8M→$40.2M6 prior comparisons
Operating income increased 65.3%
Operating income changed +65.3% from the comparable as-filed period.
-$43.9M→-$15.2M3 prior comparisons
Operating margin moved 1601 bp higher
Operating margin changed +1601 basis points from the comparable as-filed period.
-23.44%→-7.43%3 prior comparisons
Net income increased 64.0%
Net income changed +64.0% from the comparable as-filed period.
-$40.0M→-$14.4M3 prior comparisons
Gross margin moved 212 bp lower
Gross margin changed -212 basis points from the comparable as-filed period.
89.73%→87.61%3 prior comparisons
SBC / revenue moved 801 bp lower
SBC / revenue changed -801 basis points from the comparable as-filed period.
25.72%→17.71%3 prior comparisons
Stock-based compensation decreased 24.6%
Stock-based compensation changed -24.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$48.2M→$36.3M3 prior comparisons
Revenue increased 9.5%
Revenue changed +9.5% from the comparable as-filed period.
$187.3M→$205.1M3 prior comparisons
Capex / revenue moved 103 bp higher
Capex / revenue changed +103 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.34%→1.37%2 prior comparisons
Research & development decreased 12.0%
Research & development changed -12.0% from the comparable as-filed period.
$75.1M→$66.1M3 prior comparisons
Gross profit increased 6.9%
Gross profit changed +6.9% from the comparable as-filed period.
$168.0M→$179.7M3 prior comparisons
Cash & equivalents decreased 0.1%
Cash & equivalents changed -0.1% from the comparable as-filed period.
$193.8M→$193.7M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.